The FDA has proposed removing phenylephrine, a common ingredient in decongestants, due to its ineffectiveness, which may ...

With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...

Why this news will impact the lives of people affected by Alzheimer's disease: The first disease-modifying therapies for ...

NDA submission to the FDA is anticipated in the first half of calendar year 2025. Completion of the Company’s redomicile to the State of Delaware, which was approved by the Company ... to adjustments ...

Can we protect the 5,000-year legacy of medicinal plants and their multi-billion-dollar market value from climate change?

Successful completion of the program could result in a once daily oral treatment for patients with psoriasis that may offer a convenient and effective option beyond the available injectable drugs ...

Detailed price information for Satellos Bioscience Inc (MSCLF) from The Globe and Mail including charting and trades.

While everyone's attention is focused on Mineral Resources and WiseTech, there are other companies on the ASX that are ...

Ret. MCpl. Gordon Hurley, who served in Afghanistan, says psychedelic treatments such as ketamine and psilocybin can give ...

About Pulmonem Inc. Pulmonem Inc. is a Phase III ready clinical-stage biotechnology company with a granted IND from the FDA and a CTA approval from Health Canada ... Corp. Adaptogenics Health Corp. is ...

Following a hotly contested election, Donald Trump is once again the president-elect and will return to the White House on ...

WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that it has received Health Canada approval of its ...